Hypotrichosis Clinical Trial
Official title:
The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety
A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01448525 -
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
|
Phase 4 | |
| Completed |
NCT00958035 -
Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis
|
Phase 4 | |
| Completed |
NCT01891487 -
Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows
|
Phase 4 | |
| Completed |
NCT01387906 -
Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
|
Phase 4 | |
| Recruiting |
NCT05790941 -
Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation
|
Early Phase 1 | |
| Recruiting |
NCT05723198 -
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
|
Phase 3 | |
| Completed |
NCT00907426 -
Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin
|
Phase 3 |